Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07210515 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Study acronym: CRPS-RISE
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 26 to 27v18
  2. Study sites: 24 to 26v17
  3. Study sites: 22 to 24v16
  4. Study sites: 21 to 22v15
  5. Study sites: 19 to 21v14
  6. Study sites: 18 to 19v13
  7. Trial sites expanded: 15 → 18 locationsv12
  8. Study sites: 14 to 15v11
  9. Study sites: 12 to 14v10
  10. Study Status, Referencesv9
  11. Study sites: 10 to 12v8
  12. Study sites: 9 to 10v7
  13. Study sites: 7 to 9v6
  14. Study sites: 6 to 7v5 Show 4 more changesShow less
    • Start date changed from estimate of Apr 2026 to Apr 14, 2026
    • Eligibility criteria expanded, about 56 words
    • Secondary endpoints: 30 to 33
    • Study description expanded, about 1 word
  15. Study sites: 4 to 6
    • Start date: Mar 2026 to Apr 2026
    v4
  16. Study sites: 2 to 4v3
  17. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    v2
  18. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1
Trial Details
NCT Number NCT07210515
Lead Sponsor Ambros Therapeutics, Inc.
Conditions
(from sponsor)		 Complex Regional Pain Syndrome Type I
Related terms Complex Regional Pain Syndromes, Edema, Pain, Reflex Sympathetic Dystrophy
Enrollment 270 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov